Stock VRCA VERRICA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Verrica Pharmaceuticals Inc.

Equities

VRCA

US92511W1080

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
8.67 USD -5.25% Intraday chart for Verrica Pharmaceuticals Inc. +8.38% +18.44%
05-15 Verrica Pharmaceuticals Amends Licensing Agreement With Torii Pharmaceutical for Phase 3 Trial of Ycanth MT
05-15 Verrica Pharmaceuticals Inc. Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study Ycanth for the Treatment of Common Warts CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
VERRICA PHARMACEUTICALS INC.
Other Pharmaceuticals
-5.25%+8.38%+18.44%+46.21%-1.48% 368M
Bullish
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. VRCA Stock
  4. Charts Verrica Pharmaceuticals Inc.
  5. Comparison Chart